AI Segmentation

The AI Segmentation software employs a cloud-hosted, hybrid approach combining deep learning and classical algorithms to automate the delineation of organs at risk from CT images for radiation therapy planning. Its purpose is to provide an initial contouring framework for various anatomical sites, requiring subsequent review, potential modification, and approval by clinical experts within a separate treatment planning system to aid in the efficiency of the planning process.

Varian's AI Segmentation is a cloud-based, web application software designed to assist medical professionals in radiation therapy treatment planning. It utilizes a combination of deep learning and classical algorithms to automatically segment organs at risk from CT images across predefined anatomical regions: head and neck, thorax, pelvis, and abdomen. The software provides tools for visualizing these automatically generated structures, which are then intended for export into a compatible treatment planning system, such as Varian's Eclipse. The AI algorithms employed are static and non-adaptive, meaning their behavior does not change based on user input over time, and the system itself does not include manual editing or contouring tools. The primary function of AI Segmentation is to provide an initial set of anatomical contours derived from CT scans, thereby facilitating the radiation therapy planning workflow. It is explicitly stated that the software is not intended to provide clinical decisions, medical advice, or evaluations of radiation plans or treatment procedures. All segmentation results generated by the AI must be thoroughly reviewed, edited as necessary, and ultimately approved by qualified radiation therapy treatment planners and physicians within the external treatment planning system. The device's performance was established through software verification and validation testing according to industry standards, without the use of animal or clinical studies, demonstrating its capability to perform as intended under specified use conditions.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific deep learning architectures and classical algorithms are combined in the AI Segmentation software, and how does this hybrid approach enhance segmentation accuracy or efficiency compared to standalone methods?; How does the AI Segmentation's performance, quantified by metrics like Dice Similarity Coefficient or Hausdorff Distance, vary across different anatomical regions (head/neck, thorax, pelvis, abdomen) and for specific organs at risk, particularly those with low contrast or complex boundaries?; Considering its cloud-based deployment, what are the specific data security, patient privacy (e.g., HIPAA compliance), and data integrity measures implemented for the transfer, storage, and processing of CT image data?; Given that the AI algorithms are static and non-adaptive, what is the proposed lifecycle for model updates or retraining to incorporate advancements, address newly identified limitations, or adapt to evolving imaging protocols?; How does the integration of AI Segmentation (which lacks internal manual editing tools) into the Eclipse Treatment Planning System specifically impact the overall workflow efficiency and time spent by radiation therapy planners on contouring tasks compared to traditional methods or the predicate device?